{
  "id": "90e26baa34dd5ec0",
  "title": "First Treatment for Menkes Disease : FDA Approves Copper Histidinate",
  "description": "20260113T214500Z",
  "content": "",
  "source": "empr.com",
  "source_url": "https://www.empr.com/news/first-treatment-for-menkes-disease-fda-approves-copper-histidinate/",
  "published_at": "20260113T214500Z",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.empr.com/news/first-treatment-for-menkes-disease-fda-approves-copper-histidinate/",
    "url_mobile": "",
    "title": "First Treatment for Menkes Disease : FDA Approves Copper Histidinate",
    "seendate": "20260113T214500Z",
    "socialimage": "https://www.empr.com/wp-content/uploads/sites/7/2026/01/Zycubo-Sentynl-Therapeutics.png",
    "domain": "empr.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}